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Abstract
Problem/Condition: Since the first U.S. infant conceived with Assisted Reproductive Technology (ART) was born in 1981, both 
the use of advanced technologies to overcome infertility and the number of fertility clinics providing ART services have increased 
steadily in the United States. ART includes fertility treatments in which both eggs and sperm are handled in the laboratory (i.e., 
in vitro fertilization [IVF] and related procedures). Women who undergo ART procedures are more likely to deliver multiple-birth 
infants than those who conceive naturally because more than one embryo might be transferred during a procedure. Multiple births 
pose substantial risks to both mothers and infants, including pregnancy complications, preterm delivery, and low birthweight 
infants. This report provides state-specific information on U.S. ART procedures performed in 2010 and compares infant outcomes 
that occurred in 2010 (resulting from procedures performed in 2009 and 2010) with outcomes for all infants born in the United 
States in 2010.
Reporting Period Covered: 2010.
Description of System: In 1996, CDC began collecting data on all ART procedures performed in fertility clinics in the United 
States and U.S. territories, as mandated by the Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA) (Public 
Law 102-493). Data are collected through the National ART Surveillance System (NASS), a web-based data collecting system 
developed by CDC.
Results: In 2010, a total of 147,260 ART procedures performed in 443 U.S. fertility clinics were reported to CDC. These 
procedures resulted in 47,090 live-birth deliveries and 61,564 infants. The largest numbers of ART procedures were performed 
among residents of six states: California (18,524), New York (excluding New York City) (14,212), Illinois (10,110), Massachusetts 
(9,854), New Jersey (8,783), and Texas (8,754). These six states also had the highest number of live-birth deliveries as a result of 
ART procedures and together accounted for 48.0% of all ART procedures performed, 45.0% of all infants born from ART, and 
45.0% of all multiple live-birth deliveries but only 34.0% of all infants born in the United States and U.S. territories. Nationally, 
the average number of ART procedures performed per 1 million women of reproductive age (15–44 years), which is a proxy 
indicator of ART use, was 2,331. In 13 states (California, Connecticut, Delaware, Hawaii, Illinois, Maryland, Massachusetts, New 
Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Virginia), this proxy measure was higher than the national 
rate, and in four states (Connecticut, Massachusetts, New Jersey, and New York) and the District of Columbia, it exceeded twice 
the national rate. Nationally, among cycles in which at least one embryo was transferred, the average number of embryos transferred 
increased with increasing age (2.0 among women aged <35 years, 2.4 among women aged 35–40 years, and 3.0 among women 
aged >40 years). Elective single-embryo transfer (eSET) rates decreased with increasing age (10.0% among women aged <35 years, 
3.8% among women aged 35–40 years, and 0.6% among women aged >40 years). ESET rates also varied substantially between 
states (range: 0 to 45.0% among women aged <35 years). 
The number of ART births as a percentage of total infants born in the state or territory is considered as another measure of ART 
use. Overall, ART contributed to 1.5% of U.S. births (range: 
0.1% in Guam to 4.8% in Massachusetts) with the highest rates 
(>3.5% of all infants born) observed in four states (Connecticut, 
Massachusetts, New Jersey, and New York), and the District of 
Columbia. The proportion of ART births was ≤2.5% in the 
remaining states and territories. Infants conceived with ART 
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Introduction
Since the birth of the first U.S. infant conceived with Assisted 
Reproductive Technology (ART) in 1981, use of advanced 
technologies to overcome infertility has increased steadily, 
as has the number of fertility clinics providing ART services 
and procedures in the United States (1). In 1992, Congress 
passed the Fertility Clinic Success Rate and Certification Act 
(FCSRCA; Public Law 102-493), which requires that all U.S. 
fertility clinics performing ART procedures report data to CDC 
annually on every ART procedure performed. In 1997, CDC 
published the first annual ART Success Rates Report under 
FCSRCA, which reported on ART procedures performed in 
1995 (2). CDC uses the data it receives to report pregnancy 
success rates for all ART programs and clinics in the annual 
ART Success Rates Report (1). Several measures of success 
for ART are presented in the annual report including the 
percentage of ART cycles that result in a pregnancy, live-birth 
deliveries, and singleton live births. Starting with the 2010 data, 
the ART Success Rates Report was published in two separate 
reports: a Fertility Clinic Success Rates Report and a National 
Summary Report (1,3).
ART is associated with potential risks to the mother and 
fetus. Because multiple embryos are transferred in the majority 
of ART procedures, ART has been associated with a substantial 
risk for multiple-gestation pregnancy and multiple births 
(4–11). Multiple births are associated with greater health 
problems for mothers and infants, including higher rates of 
comprised 20.0% of all multiple-birth infants (range: 0 in Guam to 40.5% in Massachusetts), 19.0% of all twin infants (range: 
0 in Guam to 40.0% in Massachusetts), and 33.0% of triplet or higher order infants (range: 0 in several states to 60.0% in 
Arizona). Among infants conceived with ART, 46.0% were born in multiple deliveries (range: 0 in Guam to 55.4% in Utah), 
compared with only 3.0% of infants among all births in the general population (range: 1.3% in Guam to 4.7% in Connecticut). 
A substantial proportion (43.4%) of ART-conceived infants were twin infants, and a smaller proportion (3.0%) were triplets and 
higher order infants.
Nationally, infants conceived with ART comprised 5.6% of all low birthweight (<2,500 grams) infants (range: 0 in Guam to 16.0% 
in Massachusetts) and 5.6% of all very low birthweight (<1,500 grams) infants (range: 0 in Guam to 15.8% in Massachusetts). 
Overall, among ART-conceived infants, 31.6% were low birthweight (range: 22.6% in New Hampshire to 48.2% in Puerto 
Rico), compared with 8.0% among all infants (range: 5.7% in Alaska to 12.6% in Puerto Rico); 5.6% of ART infants were very 
low birthweight (range: 1.9% in Maine to 14.3% in Montana), compared with 1.4% among all infants (range: 0.9% in Alaska 
to 2.3% in the District of Columbia). Finally, ART-conceived infants comprised 4.4% of all infants born preterm (<37 weeks; 
range: 0 in Guam to 13.3% in Massachusetts) and 4.9% of all infants born very preterm (<32 weeks; range: 0 in Guam to 16.2% 
in Massachusetts). Overall, among infants conceived with ART, 36.6% were born preterm (range: 23.6% in New Hampshire to 
56.8% in Wyoming), compared with 12.0% among all infants born in the general population (range: 8.4% in Vermont to 17.9% 
in Guam); 6.6% of ART infants were born very preterm (range: 0 in Maine to 14.5% in Puerto Rico), compared with 2.0% 
among all infants born in the general population (range: 1.3% in Alaska to 3.0% in the District of Columbia).
Interpretation: The percentage of infants conceived with ART varied considerably by state and territory (range: 0.1% to 4.8%). 
In most states, multiples from ART comprised a substantial proportion of all twin, triplet, and higher-order infants born in the 
state, and the rates of low birthweight and preterm infants were disproportionately higher among ART infants than in the birth 
population overall. Even among women aged <35 years, for whom single embryo transfers should be considered (particularly in 
patients with a favorable prognosis) according to American Society of Reproductive Medicine (ASRM) guidelines, on average, 
two embryos were transferred per cycle in ART procedures, influencing the overall multiple infant rates in the United States. ART 
use per population unit was distributed disproportionately in the United States, with only 13 states showing ART use above the 
national rate, which might suggest barriers to ART services in the remaining states. Of the four states (Illinois, Massachusetts, 
New Jersey, and Rhode Island) with comprehensive statewide-mandated health insurance coverage for ART procedures (e.g., 
coverage for at least four cycles of IVF), three states (Illinois, Massachusetts, and New Jersey) also had rates of ART use >1.5 
times the national level. This type of mandated insurance has been associated with greater use of ART and might account for the 
differences observed in other states.
Public Health Actions: Reducing the number of embryos transferred per ART procedure among all age groups and promotion 
of eSET procedures, when clinically appropriate, is needed to reduce multiple births, including twin births, and related adverse 
consequences of ART. Improved patient education and counseling on the risks of twins might be useful in reducing twin births 
because twins account for the majority of multiples. Although ART contributes to increasing rates of multiple births, it does not 
explain all of the increases, and therefore the possible role of non-ART fertility treatments warrants further study.
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caesarean deliveries, prematurity, low birthweight, infant death, 
elevated risk of birth defects, and disability (4–15). Further, 
even singleton infants conceived with ART have a higher risk 
of low birthweight (16,17).
This report is based on ART surveillance data reported 
to CDC’s Division of Reproductive Health for procedures 
performed in 2010. Data are presented regarding the use of 
ART in each U.S. state and territory as well as infant outcomes 
in 2010 resulting from procedures performed in 2009 and 
2010. Additionally, the report examines the contribution of 
ART to selected adverse outcomes (e.g., multiple birth, low 
birthweight, and preterm delivery) and compares 2010 ART 
infant outcomes to outcomes among all infants born in the 
United States in 2010.
Methods
National ART Surveillance System
In 1996, CDC initiated data collection of ART procedures 
performed in the United States. ART data for 1995–2003 
were obtained from the Society of Assisted Reproductive 
Technology (SART). Since 2004, CDC has contracted 
with Westat, Inc., a statistical survey research organization, 
to obtain data from fertility clinics in the U.S through the 
National ART Surveillance System (NASS), a web-based data 
collection system developed by CDC (http://www.cdc.gov/
art/NASS.htm). Clinics enter their data into NASS and verify 
the data’s accuracy before sending the data to Westat. The 
data then are compiled by Westat and reviewed by both CDC 
and Westat. A few clinics (7.0%) do not report their data to 
CDC and are listed as nonreporting programs in the Fertility 
Clinic Success Rates Report as required by FCSRCA. Because 
nonreporting clinics tend to be smaller, NASS is estimated 
to contain information on >97.0% of all ART cycles in the 
United States (1).
Data collected include patient demographics, medical history, 
and infertility diagnoses; clinical information pertaining to the 
ART procedure type; and information regarding resultant 
pregnancies and births. The data file is organized with one 
record per ART procedure (or cycle of treatment) performed. 
Multiple procedures from individual patients are not linked. 
Because ART providers typically do not provide continued 
prenatal care after a pregnancy is established, information on 
live births for all procedures is collected by ART clinics either 
directly from their patients (83.0%) or from their patients’ 
obstetric providers (17.0%).
ART Procedures
ART includes fertility treatments in which both eggs and 
sperm are handled in the laboratory (i.e., in vitro fertilization 
[IVF] and related procedures). ART does not include 
treatments in which only sperm are handled (i.e., intrauterine 
insemination) or procedures in which a woman takes drugs 
only to stimulate egg production without the intention of 
having eggs retrieved. Because an ART procedure consists 
of several steps over an interval of approximately 2 weeks, a 
procedure often is referred to as a cycle of treatment. An ART 
cycle generally begins with drug-induced ovarian stimulation. 
If eggs are produced, the cycle progresses to the egg-retrieval 
stage. After the eggs are retrieved, they are combined with sperm 
in the laboratory through IVF. If this is successful, the most 
viable embryos (i.e., those that are morphologically most likely 
to develop and implant) are selected for transfer by clinicians. 
If an embryo implants in the uterus, a clinical pregnancy is 
diagnosed by the presence of a gestational sac detectable by 
ultrasound. Most pregnancy losses occur within the first 12 
weeks. Beyond 12 weeks of gestation, the pregnancy usually 
progresses to a live-birth delivery (with survival probabilities 
ranging from 95.0% at 16 weeks to 98.0% at 20 weeks), which 
is defined as the delivery of one or more live-born infants (18).
ART procedures are classified into four types based on the 
source of the egg (patient or donor) and the status of the 
embryos (fresh or thawed). Both fresh and thawed embryos 
might result from either the patient’s eggs or from the donor’s 
eggs. ART procedures involving fresh embryos include an egg-
retrieval stage. ART procedures that use thawed embryos do not 
include egg retrieval because the eggs were fertilized during a 
previous procedure, and the resulting embryos were frozen until 
the current procedure. An ART procedure can be discontinued 
at any step for medical reasons or by patient choice.
Variables and Definitions
ART data and outcomes from ART procedures are presented 
by the patient’s state or territory of residence at the time of 
treatment. If this information was missing, the state or territory 
of residence was assigned as the state or territory in which the 
procedure was performed. Cycles among non-U.S. residents 
are included in NASS data but might be excluded from some 
calculations for which the exact denominators were not known.
This report presents data on all cycles initiated; however, 
outcomes are based on cycles that involved embryo transfer. 
The number of ART procedures performed per 1 million 
women in the reproductive age (15–44 years) was calculated, 
and the resulting ratio approximates the proportion of 
women of reproductive age who used ART in each state or 
territory. However, this proxy measure of ART use is only an 
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approximation because some women who used ART might fall 
outside the age range of 15–44 years, and some women might 
have had more than one procedure during the reporting period.
Live-birth delivery was defined as birth of one or more live-
born infants, with delivery of multiple infants counted as one 
live-birth delivery. A singleton live-birth was defined as a birth 
of one live-born infant from a single gestation pregnancy. A 
multiple birth was defined as a birth of two or more infants, 
at least one of whom was live-born.
Elective single-embryo transfer (eSET) is a procedure in 
which one embryo, selected from a larger number of available 
embryos, is placed in the uterus, with extra embryos available for 
cryopreservation. This procedure does not include cycles in which 
only one embryo is available. Transfer procedures in which only 
one embryo was transferred but no embryos were cryopreserved 
also are excluded from this definition. The embryo selected for 
eSET might be from a previous IVF cycle (e.g., cryopreserved 
[frozen] embryos) or from the current fresh IVF cycle that yielded 
more than one embryo. The remaining embryos might be set aside 
for future use through cryopreservation. In this report, both eSET 
procedures and the average number of embryos transferred were 
calculated only for fresh, nondonor cycles in which at least one 
embryo was transferred.
The average number of embryos transferred for three age 
groups (<35 years, 35–40 years, and >40 years) was calculated 
by dividing the total number of embryos transferred by the total 
number of embryo-transfer procedures performed in that age 
group. The percentage of eSET was calculated by dividing the 
total number of transfer procedures in which only one embryo 
was transferred and one or more embryos were cryopreserved, 
by this numerator plus the total number of transfer procedures 
in which more than one embryo were transferred.
The contribution of ART to an outcome was calculated by 
dividing the total number of outcomes among ART-conceived 
pregnancies by the total number of overall outcomes. The 
contribution of ART to all infants born was calculated by 
plurality (singleton, multiples, twins, and triplets or higher order 
births) and by adverse perinatal outcomes (low birthweight and 
prematurity). The contribution of ART to total infants born 
in the state or territory was used as a second measure of ART 
use. The number and percentage of infants (ART-conceived 
and all infants) born in the state or territory were calculated for 
singletons, multiples, twins, and triplets or higher order births 
and for different categories of birthweight and gestational age.
Low birthweight was defined as <2,500 grams, moderate low 
birthweight as 1,500–2,500 grams, very low birthweight as 
<1,500 grams, and extremely low birthweight as <1,000 grams. 
For comparability with births to women who did not undergo 
ART, for which gestational age is based on the date of the last 
menstrual period (LMP), gestational age was calculated for 
fresh cycles by subtracting the date of retrieval from the birth 
date and adding 14 days. For frozen cycles, and for fresh cycles 
for which the date of retrieval was not available, gestational age 
was calculated by subtracting the date of transfer from the birth 
date and adding 17 days (to account for an average of 3 days in 
embryo culture). Preterm delivery was defined as gestational age 
<37 weeks, moderate preterm delivery as gestational age 32–36 
weeks, very preterm delivery as gestational age <32 weeks, and 
extremely preterm delivery as gestational age <28 weeks (19).
Content of This Report
This report provides information on U.S. ART procedures 
performed in 2010 and compares infant outcomes that occurred 
in 2010 (resulting from procedures performed in 2009 and 
2010) with outcomes for all infants born in the United States 
in 2010. Specifically, this report provides data on the number 
and outcomes of all ART procedures performed in the 50 
states, the District of Columbia, Guam, the Federated Republic 
of Micronesia, the Commonwealth of Puerto Rico, and the 
U.S. Virgin Islands in 2010.* Live-birth delivery rates, the 
number of live-born infants, live singleton and multiple birth 
deliveries, and data regarding the number of ART procedures 
in relation to the number of women in the reproductive age 
group (15–44 years) are reported (20).† Data also are presented 
on the number of embryo-transfer procedures performed, the 
average number of embryos transferred, and the percentage of 
eSET procedures performed among women who used fresh 
embryos from their own eggs, by age group, for each state 
and territory.
For each state and territory, the proportion of singleton, 
multiple, twin, and triplet or higher order infants resulting 
from ART are compared with their respective ratios among 
all infants born in that state in 2010. Infants born in the 
state or territory during that year include those that were 
conceived naturally as well as those resulting from ART and 
other infertility treatments. So that the proportion of ART 
births among overall U.S. births in 2010 could be assessed 
accurately, ART births were aggregated from 2 reporting years: 
1) infants conceived from ART procedures performed in 2009 
and born in 2010 (approximately 69.0% of the live-birth 
deliveries reported to the ART surveillance system for 2010) 
and 2) infants conceived from ART procedures performed in 
2010 and born in 2010 (approximately 31.0% of the live-
birth deliveries reported to the ART surveillance system for 
2010). Data on the total number of live-birth and multiple 
* Numbers <20 are not reported to preserve confidentiality but are included in 
totals.
† Data regarding population size are based on July 1, 2010, estimates from the 
U.S. Census Bureau (20).
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birth infants in each state and territory in 2010 were obtained 
from U.S. natality files (21). The report presents the number 
and percentage of select adverse perinatal outcomes (low 
birthweight, moderate low birthweight, very low birthweight, 
preterm delivery, moderate preterm delivery and very preterm 
delivery) among ART- conceived infants and all infants, as 
well as the contribution of ART to these outcomes. Finally, 
results for New York City are presented separately from the 
rest of the state because New York City is an independent vital 
registration reporting area (21). Therefore, unless otherwise 
specified, references in this report to New York include only 
New York state and exclude New York City.
Results
Overview of Fertility Clinics
Of 474 fertility clinics in the U.S. states and territories that 
performed ART procedures in 2010, a total of 443 (93.0%) 
provided data to CDC (Figure 1) with the majority located in 
or near major cities in the eastern United States. The number of 
fertility clinics performing ART procedures varied by state. States 
with the largest number of fertility clinics reporting data for 2010 
were California (62), New York (including New York City) (37), 
Texas (34), Illinois (28), Florida (28), and New Jersey (22).
Number and Type of ART Procedures
The number, type, and outcome of ART procedures 
performed in 2010 are provided for the 50 states, the District 
of Columbia, New York City, and five U.S. territories (Table 1). 
State residency data were missing for approximately 3.5% of 
procedures performed and 3.0% of live-birth deliveries but are 
included in the total. Approximately 16.0% of ART cycles were 
conducted among out-of-state residents. Non-U.S. residents 
accounted for approximately 2.0% of ART procedures, live-
birth deliveries, and infants born.
Nationally, a total of 147,260 ART procedures were reported 
to CDC (Table 1). Of the 147,260 procedures performed, 
125,396 (85.2%) progressed to embryo transfer (Table 1). 
Overall, 46.1% (57,773 of 125,396 ) of ART procedures 
that progressed to the transfer stage resulted in a pregnancy, 
37.6% (47,090 of 125,396) resulted in a live-birth delivery, 
26.4% (33,128 of 125,396) resulted in a singleton live-birth 
delivery, and 11.1% (13,962 of 125,396) resulted in a multiple 
live-birth delivery. The 47,090 live-birth deliveries from ART 
procedures performed in 2010 resulted in 61,564 infants 
(33,128 singleton live-birth deliveries and 13,962 multiple 
live-birth deliveries) (Table 1; Figure 2).
Six states (California, Illinois, Massachusetts, New Jersey, 
New York, and Texas) had the highest number of ART 
procedures performed among residents: California (18,524), 
New York (excluding New York City) (14,212), Illinois 
(10,110), Massachusetts (9,854), New Jersey (8,783) and 
Texas (8,754) (Table 1). Overall, these six states accounted for 
47.7% of all ART procedures performed in the United States. 
Correspondingly, the number of procedures that progressed to 
embryo transfers was the highest in these six states (California: 
16,072; New York: 12,041; Massachusetts: 8,488; Illinois: 
8,079; Texas: 7,685; and New Jersey: 7,478) and accounted for 
47.7% of all embryo transfer procedures in the United States. 
The number and percentage of ART-conceived infants born 
were highest in these six states (California: 7,725 [12.5%]; 
New York: 4,745 [7.7%]; Texas: 4,413 [7.2%]; New Jersey: 
3,856 [6.3%]; Illinois: 3,714 [6.0%]; Massachusetts: 3,403 
[5.5%]) and accounted for 45.2% of all infants born from 
ART in the United States but only 34.0% of all U.S. births 
(21). Multiple live-birth deliveries were also highest among 
these states (California: 1,781 [12.8%]; Texas: 1,101 [7.9%]; 
New York: 995 [7.1%]; New Jersey: 929 [6.7%]; Illinois: 819 
[5.9%]; Massachusetts: 667 [4.8%]) and accounted for 45.1% 
of all ART multiple live-birth deliveries (6,292/13,962).
The number of ART procedures per million women of 
reproductive age varied from 266 in Puerto Rico to 7,296 
in Massachusetts, with an overall national ratio of 2,331 
procedures per 1 million women of reproductive age. Thirteen 
states (California, Connecticut, Delaware, Hawaii, Illinois, 
Maryland, Massachusetts, New Hampshire, New Jersey, New 
FIGURE1. Location of clinics that perform assisted reproductive 
technology (ART) procedures — United States, 2010* 
28–62
20–27 
8–19
1–7
0
DC
GU
Abbreviations: DC = District of Columbia; GU = Guam.
*  In 2010, of 479 ART clinics in the United States, 443 submitted data.
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York, Pennsylvania, Rhode Island, and Virginia), New York 
City, and the District of Columbia had ratios higher than the 
national ratio. Five of these had ratios exceeding twice the 
national level (Massachusetts (7,296), New York (excluding 
New York City) (6,653), the District of Columbia (5,763), 
New Jersey (5,056), and Connecticut (4,996), and two states 
(Illinois and Maryland) had ratios exceeding one and half times 
the national level (3,844 and 4,167, respectively) (Figure 3).
Embryo Transfer and Patient’s Age
The number of embryo-transfer procedures performed, the 
average number of embryos transferred per procedure, and 
the percentage of eSET procedures performed among women 
who used fresh embryos from their own eggs are provided by 
age group (Table 2). Overall, the highest number of embryo-
transfer procedures performed was among women aged <35 
years and lowest among women aged >40 years. Nationally, 
the average number of embryos transferred per procedure 
varied from 2.0 among women aged <35 years (range: 1.7 to 
2.5) to 2.4 among women aged 35–40 years (range: 1.9 to 
4.0), and 3.0 among women aged >40 years (range: 2.0 to 
5.0). In 11 states (California, Connecticut, Georgia, Hawaii, 
Maryland, Massachusetts, New York, Rhode Island, Vermont, 
Virginia, and Washington), the District of Columbia, New 
York City, and Puerto Rico, more embryo-transfer procedures 
were performed among women aged 35–40 years than among 
younger women. Rates of eSET procedures varied by age group 
and by state and territory and were highest among women 
aged <35 years and lowest among women aged >40 years. 
Nationally, rates of eSET ranged from 10.0% among women 
aged <35 years (range: 0 in Guam and Idaho to 45.0% in 
Delaware) to 3.8% among women aged 35–40 years (range: 
0 in several states to 34.0% in Delaware) and 0.6% among 
women aged >40 years (range: 0 in most states to 7.7% 
in Alabama). Among women aged <35 years, eSET rates 
exceeded the national rate in 18 states (Arkansas, California, 
Connecticut, Delaware, Georgia, Illinois, Iowa, Kansas, Maine, 
Massachusetts, Maryland, Montana, New Hampshire, South 
Dakota, Tennessee, Virginia, Washington, and West Virginia), 
the District of Columbia, and the Virgin Islands.
Singleton and Multiple Births
Among 4,046,553 infants born in the U.S in 2010, a total 
of 59,119 (1.5%) were conceived with ART procedures 
performed in 2009 and 2010 (Tables 3 and 4). California, 
Texas, and Florida ranked among the three highest states 
FIGURE 2. Number of outcomes of assisted reproductive technology cycles, by stage — United States, 2010
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in total U.S. births. ART-conceived births were highest in 
California, followed by Texas and New York.
Approximately 0.1% (in Guam) to 4.8% (in Massachusetts) 
of infants were born with ART. The contribution of ART to all 
infants born in the state was highest in Massachusetts followed 
by New York (excluding New York City) (3.8%), Connecticut 
(3.7%), the District of Columbia (3.7%) and New Jersey 
(3.6%) (Table 3).
Although singletons accounted for 96.5% of total infants 
born in 2010, singletons accounted for only 53.6% of all ART 
infants (range: 44.6% in Utah to 65.7% in Delaware). The 
percentage of singletons among all infants ranged from 95.3% 
in Connecticut to 98.7% in Guam.
Nationwide, 46.4% (range: 0 in Guam to 55.4% in Utah) 
of ART infants were multiples compared with only 3.4% 
(range: 1.3% in Guam to 4.7% in Connecticut) of all infants 
(Table 4). ART multiple-birth infants represent 19.8% (range: 
0 in Guam to 40.5% in Massachusetts) of total multiple-
birth infants. Approximately 43.4% (range: 0 in Guam to 
52.0% in Oklahoma) of all ART-conceived infants were 
twins compared with only 3.3% (range: 1.8% in Puerto Rico 
to 4.5% in Connecticut) of all infants. ART-conceived twin 
infants accounted for 19.2% (range: 0 in Guam to 40.2% in 
Massachusetts) of all twins born in 2010. Finally, 3.0% of 
ART-conceived infants were triplets or higher order multiples 
(range: 0 in several states to 10.8% in Puerto Rico) compared 
with only 0.1% (with very little variation by state) of all infants. 
ART triplet or higher order multiple infants contributed to 
32.5% (range: 0 in several states to 60.0% in Arizona) of all 
triplet or higher order infants born in 2010.
Adverse Perinatal Outcomes
Nationally, ART infants represented approximately 5.6% 
of all low birthweight, very low birthweight, and moderate 
low birthweight infants (Table 5). The contribution of ART 
to low birthweight infants ranged from 0 in Guam to 16.0% 
in Massachusetts. The contribution of ART to very low 
birthweight infants ranged from 0 in Guam to 15.8% in 
Massachusetts. The contribution of ART to moderate low 
birthweight infants ranged from 0 in Guam to 16.0% in 
Massachusetts. In four states (Connecticut, Massachusetts, 
New Jersey, and New York [excluding New York City]) >10.0% 
of all low birthweight, moderate low birthweight, and very low 
birthweight infants born were conceived with ART.
In all states and territories, rates of low birthweight, very low 
birthweight, and moderate low birthweight infants were higher 
among infants conceived with ART than among all infants 
(Table 5). Among ART infants, 31.6% were low birthweight 
infants (range: 22.6% in New Hampshire to 48.2% in Puerto 
Rico), compared with 8.2% among all infants (range: 5.7% 
in Alaska to 12.6% in Puerto Rico). Approximately 5.6% of 
ART infants were very low birthweight infants (range: 1.9% 
in Maine to 14.3% in Montana), compared with 1.4% among 
all infants (range: 0.9% in Alaska to 2.3% in the District 
of Columbia). Approximately 26.0% of ART infants were 
FIGURE 3. Number of procedures performed using assisted reproductive technology among women* of reproductive age (ages 15–44 years), 
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moderately low birthweight infants (range: 18.1% in Montana 
to 35.8% in Oklahoma), compared with 6.7% among all infants 
(range: 4.8% in Alaska to 11.3% in Puerto Rico). (Table 5). 
In additional analyses, 2.0% of ART infants were born with 
a birthweight of less than 1,000g (range: 0 in Alaska, Maine, 
Vermont, and Wyoming to 8.6% in Montana). Among all very 
low birthweight (<1,500 g) ART-conceived infants, 39.0% were 
born with extremely low birthweight (ELBW) of <1,000g.
Nationally, infants conceived with ART contributed 
approximately 4.4%, 4.9%, and 4.4% respectively to all 
preterm, very preterm, and moderate preterm infants (Table 6). 
The contribution of ART to preterm infants ranged from 0 in 
Guam to 13.3% in Massachusetts. The contribution of ART 
to very preterm infants ranged from 0 in Guam to 16.2% 
in Massachusetts. The contribution of ART to moderate 
preterm birth infants ranged from 0 in Guam to 12.8% in 
Massachusetts. In four states (Connecticut, Massachusetts, 
New Jersey, and New York), >10.0% of all preterm, very 
preterm, and moderate preterm infants in the state were 
conceived with ART.
As with low birthweight, rates of preterm, very preterm, and 
moderate preterm infants were higher among ART infants than 
in the general birth population (Table 6). Among ART infants, 
36.6% were born preterm (range: 23.6% in New Hampshire to 
56.8% in Wyoming), compared with 12.0% among all infants 
(range: 8.4% in Vermont to 17.9% in Guam). Approximately, 
6.6% of ART infants were very preterm (range: 0 in Maine to 
14.5% in Puerto Rico), compared with 2.0% among all infants 
(range: 1.3% in Alaska to 3.0% in District of Columbia). 
Approximately 30.0% of ART infants were moderate preterm 
infants (range: 19.1% in New Hampshire to 45.5% in 
Wyoming), compared with 10.1% among all infants (range: 
6.9% in Vermont to 15.1% in Guam) (Table 6).
In additional analyses, 2.0% of ART infants were born 
extremely preterm at <28 weeks of gestation (range: 0 in Alaska 
and Maine to 7.6% in Montana). Among all ART-conceived 
infants born very preterm (<32 weeks), 40.0% were born 
extremely preterm (<28 weeks of gestation).
Discussion
Overview
The use of ART has increased substantially in the United 
States since the beginning of ART surveillance. In 1996 (the first 
full year for which ART data were reported to CDC), 20,597 
infants were born from 64,036 ART cycles (22). Since then, 
the number of cycles reported to CDC has more than doubled 
while the number of infants born from ART procedures has 
nearly tripled. The impact of ART on multiple infant rates and 
poor birth outcomes is substantial because almost half of ART 
infants (46.0%) were born in multiple births (compared with 
only 3.0% of infants among the general birth population). On 
average, two embryos were transferred among women aged <35 
years. National rates of eSET procedures were low, even among 
women aged <35 years. Rates of low birthweight and preterm 
births were substantially higher among ART infants (31.6% and 
36.6% respectively) than among all infants (8.0% and 12.0% 
respectively). Overall, 19.2% of all twin and 32.5% of triplet 
or higher order infants were conceived with ART.
Variations by State
ART use varied widely by state, especially after controlling 
for the size of the population of women of reproductive age. 
Residents of California, Illinois, Massachusetts, New York 
(excluding New York City), New Jersey, and Texas had 45.0% 
of all ART infants but only 34.0% of all infants born in the 
United States. Rates of ART use were not correspondingly high 
in all six states. ART use exceeded twice the national average 
in only three of these six states (Massachusetts, New Jersey, and 
New York) (as measured by the number of ART procedures 
performed per 1 million women of reproductive age). By this 
measure, Massachusetts ranked highest in ART use whereas 
California, despite having the highest overall number of ART 
procedures and the highest number of ART infants, ranked 
15th nationally. Furthermore, the contribution of ART to all 
infants born in the state was 4.8% in Massachusetts compared 
with 1.5% in California, which also indicates higher ART use in 
Massachusetts. Similarly, residents of Connecticut, the District 
of Columbia, Illinois, Maryland, New Jersey, New York, and 
New York City, in addition to residents of seven other states 
(California, Delaware, Hawaii, New Hampshire, Pennsylvania, 
Rhode island, Virginia), had higher rates of ART use than 
the national average as reflected by the high number of ART 
procedures performed per 1 million women of reproductive age.
This divergence might be explained in part by variations in 
state health insurance coverage. Currently, 15 states (Arkansas, 
California, Connecticut, Hawaii, Illinois, Louisiana, Maryland, 
Massachusetts, Montana, New Jersey, New York, Ohio, Rhode 
Island, Texas, and West Virginia) have passed legislation 
mandating insurance coverage for infertility treatments; four 
of these states (Illinois, Massachusetts, New Jersey, and Rhode 
Island) also have mandated comprehensive insurance coverage 
that must cover at least four cycles of IVF.§ Three out of the 
four states with mandates (Illinois, Massachusetts, and New 
§ Nine states (Arkansas, Connecticut, Hawaii, Louisiana, Maryland, Montana, 
New York, Ohio, and West Virginia) have restricted mandates. Two states 
(California and Texas) have other insurance regulations on ART or other 
infertility treatments but do not require coverage of ART.
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Jersey) also had rates of ART use >1.5 times the national level. 
This type of mandated insurance has been associated with 
greater use of ART (23–25).
Elective Single-Embryo Transfer Rates
Typically, younger women are better candidates for eSET 
procedures because they might have more than one embryo 
available for transfer and better prognosis. Data indicate that 
eSET rates varied by age group and also by state. ESET procedures 
were more prevalent among women aged <35 years and varied 
enormously among states (range: 0 to 45.0%). Although many 
factors (e.g., a patient’s age and diagnostic factors) influence 
eSET rates, research shows that broad insurance mandates for 
IVF might result not only in large increases in access to ART 
services but also in substantially fewer aggressive treatments, with 
fewer embryos transferred within a procedure (24,26). In the 
four states with mandatory insurance for ART, among women 
aged <35 years, eSET rates were higher than the national average 
of 10.0% in Illinois (10.7%) and Massachusetts (18.2%) but 
lower in New Jersey (4.3%) and Rhode Island (7.2%). Because 
ART procedures are expensive, attempts to reduce out-of-pocket 
costs might result in higher number of embryo transfers per 
attempt for patients who do not have insurance coverage for 
ART (24,26). In the United States, private insurance coverage 
of ART is rare, and it is estimated that approximately 20.0% of 
all ART costs are covered by state mandate of private insurers 
and/or by private insurers. Even where mandated, coverage for 
infertility treatment often varies in scope (23). The higher use of 
eSET in Illinois and Massachusetts is consistent with previous 
research linking insurance with embryo transfer practices that 
might promote eSET. This link is not evident in New Jersey 
and Rhode Island, both of which had state-mandated insurance 
for ART but lower-than-national rates of eSET procedures 
performed. ESET rates also exceeded the national average in a 
number of states that do not have mandated insurance coverage 
for ART, especially among women aged <35 years, suggesting 
compliance with American Society for Reproductive Medicine 
(ASRM)/Society for Assisted Reproductive Technology (SART) 
recommendations on eSET (27).
ART Multiple Births
Since 2000 (the first year for which state-specific data were 
reported by CDC), the percentage of ART-conceived multiple 
infants in the United States declined by 13.0% (from 53.0% 
in 2000 to 46.0% in 2010) (28). A sharp decline was noted 
in the rate of ART-conceived triplets and higher order infants 
of 67.0% (from 9.0% in 2000 to 3.0% in 2010) and a lesser 
decline in ART-conceived twin infant rates of 2.0% (from 
44.0% in 2000 to 43.0% in 2010).
Despite the decline, multiple birth rates remain high in 
the United States. On average, two embryos were transferred 
per cycle among all age groups, even among younger women 
in 2010. To control costs, patients and providers might be 
willing to transfer multiple embryos to maximize the chance 
of live-birth delivery in a single procedure (25). The expected 
association between fewer average number of embryos 
transferred and availability of mandated insurance coverage 
for ART is not wholly supported by our data. The average 
percentage of embryos transferred among women aged <35 
years in the four states with universal mandated coverage 
(Illinois, 2.0%; Massachusetts, 1.8%; New Jersey, 2.1%; 
Rhode Island, 2.0%) was similar to the national rate (2.0%). 
In addition, only in Massachusetts was the rate of ART-
conceived multiple infants (38.8%) lower than the national 
rate of ART multiple infants (46.4%). Thus, rates of ART-
conceived multiple infants varied substantially between the 
four states with mandated insurance, suggesting that the link 
between insurance and embryo transfer practices such as the 
number of embryos transferred per procedure, and multiple 
births might be complex.
Evidence suggests that infertile couples might prefer multiple 
births, especially twins, in their desire to achieve parenthood, 
and might not estimate the risks for such pregnancies accurately 
or they might weigh the risks but see the potential benefits as 
outweighing them. Infertile women might be more receptive 
to the idea of a multiple birth than fertile women (29,30). 
Therefore, understanding the viewpoint of couples undergoing 
infertility treatments about multiple births is an important 
consideration. ART providers also can vary widely in their 
clinical practices for a variety of reasons, which can affect the 
outcomes in each state; the extent that clinic practices affect 
the overall state results shown in this report depends on various 
factors including patient age and diagnostics, the number of 
cycles performed as well as the number and size of the other 
clinics in the state.
In 2010, approximately half of all ART infants were born in 
multiple births. During 1980–2009, the overall twin birth rates 
in the United States, which comprise the majority of multiple 
births, increased by 76.0%, from 18.9 to 33.3 per 1,000 births 
(31). In 2009, one in every 30 babies born in the United States 
was a twin, compared with one in every 53 babies in 1980 (31). 
The increased use of infertility treatments, both ART and non-
ART fertility treatments (ovulation stimulation medications 
without ART), likely is associated with this sharp increase 
(32). Because of the risks associated with multiple-gestation 
pregnancies, medical experts believe that the best outcome of 
IVF treatment is a singleton pregnancy followed by a singleton 
birth (33). Singleton live-birth deliveries have much lower 
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risks than multiple births for adverse birth outcomes such as 
prematurity, low birthweight, disability, and death.
The economic costs of multiple births are also much higher 
compared with singleton births. The mean medical cost of 
delivering a singleton baby was estimated to be $9,329, whereas 
a set of twins costs $20,318, and triplets have a delivery expense 
of $153,335 (34). Transferring two embryos is associated with 
a more than threefold increase in the birth rate and a more 
than 16-fold increase in the twin birth rate (35). In 2010, the 
transfer of two embryos was still a common practice, even among 
younger patients. To improve the likelihood of optimal birth 
outcomes, patients and providers should agree to transfer fewer 
numbers of embryos when possible, taking into consideration 
patient age and prognosis (36). The guidelines on the number 
of embryos transferred were revised in 2004, 2006, 2008, 2009, 
and 2012 (37–41). At its 2011 annual meeting, the American 
Society for Reproductive Medicine  Practice Committee noted 
that the most direct way to limit the risk for multiple gestations 
from ART is to transfer single embryos (27).
ART Low Birthweight Infants  
and Preterm Births
The rates of low birthweight and very low birthweight 
infants were disproportionately higher among ART infants 
than in the general birth population. Four states (Connecticut, 
Massachusetts, New Jersey, and New York) with high number 
of ART cycles and births also had high ART contributions 
(>10.0%) to all three categories of low birthweight and preterm 
births. The contribution of ART to preterm births in the United 
States, most of which are also low birthweight, is a key concern. 
Since 1981, the rate of preterm births in the United States has 
increased >30.0% (42). Fertility treatments, both ART and 
controlled ovarian stimulations, contribute substantially to 
preterm births among both multiple and singleton pregnancies 
(42). Preterm births are a leading cause of infant mortality 
and morbidity, and preterm infants are at increased risk for 
death and have more health and developmental problems than 
full-term infants (42–45). Among ART infants, a substantial 
proportion of very preterm and very low birthweight infants 
were born extremely preterm at less than 28 weeks of gestation 
and with extremely low birthweight at less than 1,000 grams. 
The health risks associated with preterm births are monumental 
and have contributed to increasing health-care costs. In 2005, 
the estimated economic burden associated with preterm births 
in the United States was $26 billion ($51,600 per infant born 
preterm) (42). In 2010, ART infants born preterm accounted for 
approximately 4.0% of all preterm births in the United States, a 
total economic burden likely to far exceed the earlier estimated 
costs of $1 billion.
Limitations
The findings in this report are subject to at least six 
limitations. First, ART surveillance data were reported for 
each ART procedure performed rather than for each patient 
who used ART. Linking procedures among patients who 
underwent more than one ART procedure in a given year is 
difficult. Second, because patients who underwent more than 
one procedure in a given year were most likely to include 
those in which a pregnancy was not achieved during that year 
but might be achieved with repeated treatments, the success 
rates reported might represent underestimates if interpreted as 
per-patient rather than per-cycle success rates. Third, from the 
available data, it is not possible to differentiate between risks 
associated with naturally conceived multiple births and risks 
associated with multiple births resulting from ART procedures. 
Prematurity and low birthweight could be associated with 
factors contributing to infertility, and not entirely to ART 
procedures. Fourth, a small percentage of fertility clinics that 
performed ART in 2010 did not report their data to CDC 
and might have had results different from clinics that reported 
their data. Fifth, four states had a substantial percentage of 
residency information missing for procedures performed in 
2010 (Hawaii: 6.7%, Georgia: 9.2%, Pennsylvania: 9.3%, and 
Massachusetts: 33.1%). Finally, overall, residency data were 
missing for approximately 4.0% of procedures performed and 
3.0% of all live-birth deliveries resulting from ART procedures 
performed in 2010.
Conclusion
During 1996–2010, the number of ART procedures 
performed in the United States doubled while the number 
of infants born as a result of these procedures nearly tripled. 
With this increasing use, ART-conceived infants now represent 
1.5% of infants born in the U.S and might have a noticeable 
impact on the prevalence of low birthweight and preterm 
deliveries in many states, as 46.4% of these infants were born 
in multiple-gestation pregnancies that resulted in multiple 
births. Furthermore, although rates of triplet or higher order 
infants have declined during the last decade, ART-conceived 
twin infant rates have remained persistently high. Therefore, 
the impact of ART on poor birth outcomes remains substantial 
despite the overall decline in multiple infant rates. This could 
be attributed to the persistently high rates of ART-conceived 
twin infants, which have declined very little in the last decade. 
This report documents the rates and contribution of ART to 
multiples, twins, and triplets, and higher order infants as well 
as low birthweight infants and preterm infants by each state/
territory and allows state health departments to monitor the 
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extent of ART-related adverse perinatal outcomes in their 
individual state and territories.
Comprehensive insurance coverage of ART might increase 
access to fertility treatments. The findings in this report indicate 
that ART use was higher than the national rate in all four states 
with mandated comprehensive insurance coverage. Three of 
these four states had utilization rates >1.5 national levels. 
However, embryo transfer practices were similar to the national 
rates in all four mandated states. The use of elective single-
embryo transfers was higher only in Massachusetts, which had 
a correspondingly lower rate of ART multiple infants. Further 
research is needed to ascertain the influence of state insurance 
mandates on ART use, embryo transfer practices, and infant 
outcomes, as well as the economic costs of multiple births 
(23–26), including out-of-pocket costs to patients. Addressing 
the risk for multiple births also requires understanding the 
perspectives of couples undergoing infertility treatments who 
might see a multiple birth, especially twins, as an acceptable 
or even desired outcome and who might not be aware of the 
increased risks associated with multiple birth to mother and 
infants. Clinicians should continue to support ongoing efforts 
to limit the number of embryos transferred to single embryo to 
reduce twin rates, which have remained high, and encourage 
wider implementation of elective single-embryo transfers, when 
clinically appropriate, as mechanisms of promoting singleton 
infant births among ART-conceived pregnancies.
CDC is working to extend the utility of NASS by linking to 
data collected by states (birth certificate, infant deaths, hospital 
discharge, birth defect registries, and cancer registries) to 
conduct state-based surveillance of ART, infertility, and related 
issues. This initiative, the States Monitoring ART (SMART) 
Collaborative,¶ has been determined to be feasible and useful, 
especially for monitoring long-term outcomes of ART (46). 
To date, data from NASS have been linked with vital records 
from three states (Florida, Massachusetts, and Michigan). 
The overarching purpose of the SMART Collaborative is 
to strengthen the capacity of states to evaluate maternal and 
perinatal outcomes and programs through state-based public 
health surveillance systems (47).
Further efforts also are needed to monitor the use of non-
ART fertility treatments and their role in the rising number 
of multiple births (42). Despite its substantial impact on 
adverse birth outcomes, ART only partially explains the 
overall prevalence of these adverse outcomes in the United 
States. Preterm births resulting from controlled ovarian 
stimulation (superovulation-intrauterine insemination and 
conventional ovulation induction) also might contribute to 
multiple gestations (42). More research is needed to identify the 
causes and consequences of preterm births that occur because 
of infertility treatments and to institute guidelines to reduce 
the number of multiple gestations (42). The risk for multiple 
gestations associated with non-ART fertility treatments is less 
well documented, as clinics are not mandated to report data 
on their use. Recent studies have demonstrated that singleton 
infants conceived with ovulation stimulation are more likely 
than naturally conceived infants to be small for gestational age 
(48). CDC is monitoring the prevalence of non-ART fertility 
treatment use among women who had live births and their 
resultant outcomes in several states through the Pregnancy Risk 
Assessment Monitoring System (PRAMS)** (49). The most 
recent ART Surveillance Summary was published by CDC in 
2012 (50). CDC will continue to provide updates of ART use 
in the United States as data become available.
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TABLE 1. Number and outcomes of assisted reproductive technology (ART) procedures, by female patient’s state/territory of residence* at 
time of treatment — United States, 2010
Patient’s state/territory 
of residence
No.  
of ART  
clinics
No.  
procedures 
performed
No.  
embryo  
transfer 
procedures†
No. 
pregnancies
No.  
live-birth 
deliveries
No.  
singleton 
live-birth 
deliveries
No.  
multiple 
live-birth 
deliveries
No. 
live-born 
infants
Procedures 
started/women 
aged 15–44 yrs 
Ratio  
(per million)§
Alabama 6 838 714 338 280 212 68 356 872.6
Alaska 1 174 146 70 54 38 —¶ 70 1,208.7
American Samoa 0 — — — — — — —
Arizona 10 2,054 1,770 872 685 489 196 891 1,624.1
Arkansas 1 497 411 196 167 115 52 219 872.2
California 62 18,524 16,072 7,409 5,880 4,099 1,781 7,725 2,349.9
Colorado 8 1,693 1,547 943 757 494 263 1,030 1,647.5
Connecticut 9 3,451 2,881 1,333 1,098 777 321 1,438 4,996.0
Delaware 2 620 494 223 168 142 26 194 3,454.9
District of Columbia** 3 939 761 331 276 221 55 331 5,762.5
Federated States of 
Micronesia
0 — — — — — — —
Florida 28 6,114 5,179 2,283 1,901 1,316 585 2,519 1,716.4
Georgia†† 9 3,026 2,702 1,260 1,052 718 334 1,400 1,458.2
Guam 0 — — — — — — —
Hawaii†† 5 748 614 274 210 134 76 289 2,858.6
Idaho 1 432 395 173 153 98 55 213 1,408.0
Illinois 28 10,110 8,079 3,537 2,871 2,052 819 3,714 3,843.6
Indiana 10 1,678 1,376 631 544 361 183 737 1,303.8
Iowa 2 1,076 895 493 418 303 115 536 1,865.6
Kansas 5 735 618 309 267 180 87 359 1,324.1
Kentucky 4 1,071 969 431 376 257 119 502 1,252.5
Louisiana 4 864 711 363 307 196 111 423 929.8
Maine 0 116 91 46 39 32 — 47 480.3
Maryland 7 4,975 4,141 1,979 1,574 1,184 390 1,965 4,166.7
Massachusetts†† 8 9,854 8,488 3,388 2,716 2,049 667 3,403 7,296.1
Michigan 12 3,311 2,833 1,301 1,053 717 336 1,413 1,729.6
Minnesota 5 2,156 1,923 1,020 859 614 245 1,105 2,061.8
Mississippi 2 382 338 134 113 82 31 146 632.7
Missouri 7 1,525 1,278 636 539 346 193 742 1,296.2
Montana 0 153 141 76 69 44 25 94 850.9
Nebraska 2 610 455 208 170 124 46 218 1,715.7
Nevada 4 1,104 930 489 421 287 134 561 2,008.2
New Hampshire 1 706 597 286 236 170 66 303 2,824.5
New Jersey 22 8,783 7,478 3,600 2,908 1,979 929 3,856 5,055.5
New Mexico 1 389 349 197 164 95 69 238 974.7
See table footnotes on page 14.
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TABLE 1. (Continued) Number and outcomes of assisted reproductive technology (ART) procedures, by female patient’s state/territory of 
residence* at time of treatment — United States, 2010
Patient’s state/territory 
of residence
No.  
of ART  
clinics
No.  
procedures 
performed
No.  
embryo  
transfer 
procedures†
No. 
pregnancies
No.  
live-birth 
deliveries
No.  
singleton 
live-birth 
deliveries
No.  
multiple 
live-birth 
deliveries
No. 
live-born 
infants
Procedures 
started/women 
aged 15–44 yrs 
Ratio  
(per million)§
New York§§ 19 14,212 12,041 4,659 3,697 2,702 995 4,745 6,653.3
New York City 18 4,756 3,887 1,615 1,229 905 324 1,559 2,487.6
North Carolina 10 2,934 2,563 1,286 1,089 721 368 1,473 1,503.4
North Dakota 1 196 157 75 63 44 — 82 1,514.8
Ohio 10 3,444 2,913 1,279 1,089 768 321 1,430 1,543.2
Oklahoma 3 701 624 320 270 173 97 371 950.4
Oregon 4 1,083 954 533 438 283 155 595 1,435.5
Pennsylvania†† 19 5,738 4,740 2,145 1,753 1,264 489 2,258 2,351.6
Puerto Rico 3 206 189 79 44 28 — 62 266.0
Rhode Island 1 721 614 237 198 152 46 244 3,360.8
South Carolina 4 1,091 953 488 428 281 147 576 1,174.4
South Dakota 1 199 183 95 82 64 — 102 1,303.6
Tennessee 8 1,099 924 433 374 275 99 478 862.2
Texas 34 8,754 7,685 3,968 3,272 2,171 1,101 4,413 1,639.0
Utah 3 995 843 429 369 234 135 507 1,646.1
Vermont 1 230 173 70 53 39 — 67 1,945.7
Virgin Islands 0 — — — — — — —
Virginia 13 5,042 4,222 1,915 1,549 1,122 427 1,982 3,046.5
Washington 11 2,718 2,385 1,261 1,044 746 298 1,349 2,002.1
West Virginia 3 282 244 108 90 61 29 119 825.1
Wisconsin 8 1,440 1,287 587 502 349 153 662 1,312.7
Wyoming 0 84 76 44 41 24 — 58 787.1
Nonresident 2,600 2,337 1,307 1,081 787 294 1,385 ¶¶
Total 443 147,260 125,396 57,773 47,090 33,128 13,962 61,564 2,330.8
 * In cases of missing residency data (4%), the patient’s state of residence was assigned as the state in which the ART procedure was performed.
 † Embryo transfer procedures include all procedures that are not cancelled and a transfer was attempted (even if no embryos were transferred, n = 14).
 § Annual Estimates of the Population for the United States, Regions, States, and Puerto Rico: April 1, 2010 to July 1, 2012 (NST-EST2012-01). Source: U.S. Census 
Bureau, Population Division. Release date: December 2012.
 ¶ Data are not provided to preserve confidentiality but are included in totals.
 ** Of all ART procedures, 0.6% were reported from military medical centers located in California, the District of Columbia, Hawaii, Maryland, and Texas. In each of 
these areas, ≥1% of ART procedures among residents were performed in a military medical center. In the District of Columbia, 12% of ART procedures among 
residents were performed in a military medical center. 
 †† A substantial percentage (5%–33%) of residency information was missing for procedures performed in these four states. Overall, residency information was missing 
for 5,189 (4%) procedures performed and 1,363 (3%) of live-birth deliveries.
 §§ Outcomes for New York state do not include New York City.
 ¶¶ Non-U.S. residents excluded from ratio because the appropriate denominators were unknown.
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TABLE 2. Number of embryo transfer procedures* among patients who used fresh embryos from their own eggs, by female patient’s age group 
and state/territory of residence† at time of treatment — United States, 2010
Patient’s state/
territory of residence
Age group (yrs)
<35 35–40 >40
No. embryo 
transfer 
procedures
Average no. 
embryos 
transferred
(mean)
eSET§  
(%)
No. embryo 
transfer
procedures
Average no. 
embryos 
transferred 
(mean)
eSET  
(%)
No.
embryo transfer 
procedures
Average no. 
embryos 
transferred 
(mean)
eSET  
(%)
Alabama 293 2.0 (4.8) 151 2.4 (0.7) —¶ 2.8 (7.7)
Alaska 46 2.3 (9.1) 40 2.4 (2.6) — 2.6 (0)
American Samoa — — — — 2.0 — — — —
Arizona 452 2.1 (8.0) 395 2.4 (3.6) 102 2.7 (2.5)
Arkansas 151 1.9 (13.7) 97 2.1 (4.8) — 2.5 (0)
California 3,394 2.1 (11.2) 4,681 2.6 (3.8) 1,926 3.2 (0.7)
Colorado 368 2.0 (5.9) 326 2.3 (3.3) 77 2.9 (0)
Connecticut 852 2.0 (10.7) 937 2.4 (4.5) 319 3.2 (0.4)
Delaware 176 1.7 (45.0) 105 1.9 (34.0) 20 2.3 (6.3)
District of Columbia 159 1.7 (29.2) 273 2.1 (9.4) 133 2.7 (0.9)
Federated States of 
Micronesia
— — — — — — — — —
Florida 1,638 2.0 (8.7) 1,479 2.4 (1.9) 436 2.7 (0.5)
Georgia** 738 2.0 (13.7) 743 2.6 (3.5) 148 3.1 (0)
Guam — — (0) — 4.0 (0) — 5.0 (0)
Hawaii** 126 2.2 (3.3) 205 2.9 (2.1) 97 2.9 (0)
Idaho 120 2.3 (0) 77 2.6 (0) — 2.2 (0)
Illinois 2,469 2.0 (10.7) 2,164 2.3 (3.6) 645 2.7 (0)
Indiana 538 2.1 (3.6) 310 2.3 (1.1) 44 2.8 (0)
Iowa 369 1.8 (22.6) 149 2.0 (9.5) 33 2.6 (0)
Kansas 232 1.9 (11.1) 139 2.2 (3.2) — 2.9 (0)
Kentucky 436 2.2 (4.5) 179 2.7 (1.7) 34 2.8 (3.3)
Louisiana 295 2.1 (1.8) 163 2.4 (0.7) 55 2.7 (0)
Maine 33 1.8 (21.4) 23 2.4 (0) — 2.0 (0)
Maryland 1,151 1.7 (25.2) 1,248 2.2 (8.3) 454 2.9 (1.0)
Massachusetts** 2,581 1.8 (18.2) 3,017 2.2 (5.5) 981 3.3 (0.2)
Michigan 923 2.2 (2.7) 670 2.5 (2.1) 144 2.8 (0)
Minnesota 727 1.8 (10.0) 483 2.1 (2.5) 96 2.7 (0)
Mississippi 135 2.1 (4.6) 77 2.4 — 24 2.9 (0)
Missouri 488 2.0 (3.7) 293 2.4 (1.1) 42 3.0 (0)
Montana 51 1.7 (21.3) 29 2.0 (4.0) — 2.9 (0)
Nebraska 192 2.0 (5.0) 96 2.4 (5.7) — 2.6 (0)
Nevada 231 2.0 (8.5) 211 2.3 (2.2) 42 2.1 (0)
New Hampshire 212 1.7 (19.3) 210 2.1 (4.5) 47 3.0 (0)
New Jersey 2,230 2.1 (4.3) 2,181 2.4 (2.8) 794 2.9 (0.3)
New Mexico 101 2.0 (9.4) 88 2.6 (5.7) 23 3.3 (0)
See table footnotes on page 16.
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TABLE 2. (Continued) Number of embryo transfer procedures* among patients who used fresh embryos from their own eggs, by female patient’s 
age group and state/territory of residence† at time of treatment — United States, 2010
Patient’s state/
territory of residence
Age group (yrs)
<35 35–40 >40
No. embryo 
transfer 
procedures
Average no. 
embryos 
transferred
(mean)
eSET§  
(%)
No. embryo 
transfer 
procedures
Average no. 
embryos 
transferred 
(mean)
eSET  
(%)
No. embryo 
transfer 
procedures
Average no. 
embryos 
transferred 
(mean)
eSET  
(%)
New York†† 3,118 2.1 (7.7) 3,542 2.5 (2.8) 1,700 2.8 (1.0)
New York City 710 2.1 (6.8) 1,218 2.5 (3.8) 791 3.0 (1.4)
North Carolina 821 2.0 (5.3) 676 2.4 (2.4) 136 3.0 (0)
North Dakota 62 2.1 (5.2) 26 2.4 (0) — — —
Ohio 1,043 2.1 (7.8) 736 2.4 (1.2) 152 3.0 (0)
Oklahoma 265 2.0 (4.5) 136 2.2 (3.2) 21 2.7 (0)
Oregon 238 2.0 (4.7) 232 2.3 (5.0) 51 3.2 (0)
Pennsylvania** 1,512 2.0 (6.9) 1,277 2.4 (3.2) 259 2.8 (0)
Puerto Rico 68 2.3 (3.0) 78 2.5 (0) — 2.9 (0)
Rhode Island 195 2.0 (7.2) 202 2.5 (3.3) 78 3.3 (0)
South Carolina 346 2.0 (2.1) 209 2.3 (1.6) 36 3.0 (0)
South Dakota 82 1.8 (26.3) 27 2.2 (4.3) — 2.6 (0)
Tennessee 306 2.1 (10.8) 212 2.3 (3.0) 32 2.5 (0)
Texas 2,585 2.0 (7.1) 2,070 2.3 (3.3) 449 2.9 (0.5)
Utah 390 1.9 (7.2) 157 2.2 (1.5) 28 2.5 (0)
Vermont 37 2.0 (5.9) 77 2.2 (8.8) — 2.7 (0)
Virgin Islands — 1.8 (20.0) — 2.0 (0) — 3.0 (0)
Virginia 1,151 1.8 (16.8) 1,294 2.2 (6.1) 342 2.9 (0.4)
Washington 593 1.8 (20.7) 642 2.3 (7.1) 184 3.0 (1.2)
West Virginia 87 2.0 (18.4) 61 2.6 (3.5) — 3.0 (0)
Wisconsin 468 2.0 (9.2) 313 2.4 (2.4) 47 2.7 (0)
Wyoming 33 2.0 (3.1) — 2.4 (0) — 2.0 (0)
Nonresident 366 2.2 (5.3) 462 2.4 (4.0) 152 2.8 (4.0)
Total 36,390 2.0 (10.0) 34,904 2.4 (3.8) 11,320 3.0 (0.6)
Abbreviation: eSET= elective Single Embryo Transfer. 
 * Include all procedures in which at least one embryo was transferred.
 † In cases of missing residency data (4%), the patient’s state of residence was assigned as the state in which the ART procedure was performed.
 § A procedure in which one embryo, selected from a larger number of available embryos, is placed in the uterus. A cycle in which only one embryo is available is not 
defined as eSET.  
 ¶ Data are not provided to preserve confidentiality but are included in totals.
 ** A substantial percentage (5%–33%) of residency information was missing for procedures performed in these four states.
 †† Outcomes for New York state do not include New York City. 
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TABLE 3. Number, percentage, and proportion of infants born with the use of assisted reproductive technology (ART), by female patient’s state/
territory of residence* at time of treatment — United States, 2010† 
Patient’s state/territory of 
residence 
No. infants  
born§
No. ART 
infants born 
Proportion of 
infants born 
who are ART 
infants (%) 
ART  
singleton  
infants¶
Singletons  
among all  
infants§
Proportion of 
ART singletons 
among all 
singletons  
(%)No. (%) No. (%)
Alabama 60,050 368 0.6 205 (55.7) 57,841 (96.3) 0.4
Alaska 11,471 60 0.5 37 (61.7) 11,128 (97.0) 0.3
Arizona 87,477 921 1.1 467 (50.7) 84,951 (97.1) 0.5
Arkansas 38,540 203 0.5 120 (59.1) 37,459 (97.2) 0.3
California 510,198 7,540 1.5 4,072 (54.0) 494,267 (96.9) 0.8
Colorado 66,355 994 1.5 469 (47.2) 64,129 (96.6) 0.7
Connecticut 37,708 1,404 3.7 767 (54.6) 35,937 (95.3) 2.1
Delaware 11,364 204 1.8 134 (65.7) 10,951 (96.4) 1.2
District of Columbia 9,165 337 3.7 189 (56.1) 8,744 (95.4) 2.2
Federated States of 
Micronesia
—** — — — — — — —
Florida 214,590 2,402 1.1 1,226 (51.0) 207,812 (96.8) 0.6
Georgia†† 133,947 1,390 1.0 697 (50.1) 129,282 (96.5) 0.5
Guam 3,414 — 0.1 — (100.0) 3,368 (98.7) 0.1
Hawaii†† 18,988 236 1.2 120 (50.8) 18,400 (96.9) 0.7
Idaho 23,198 244 1.1 113 (46.3) 22,466 (96.8) 0.5
Illinois 165,200 3,775 2.3 2,059 (54.5) 158,829 (96.1) 1.3
Indiana 83,940 705 0.8 347 (49.2) 81,261 (96.8) 0.4
Iowa 38,719 541 1.4 312 (57.7) 37,301 (96.3) 0.8
Kansas 40,649 315 0.8 155 (49.2) 39,425 (97.0) 0.4
Kentucky 55,784 453 0.8 224 (49.4) 53,986 (96.8) 0.4
Louisiana 62,379 415 0.7 210 (50.6) 60,245 (96.6) 0.3
Maine 12,970 54 0.4 30 (55.6) 12,570 (96.9) 0.2
Maryland 73,801 1,856 2.5 1,090 (58.7) 70,984 (96.2) 1.5
Massachusetts†† 72,865 3,480 4.8 2,131 (61.2) 69,535 (95.4) 3.1
Michigan 114,531 1,460 1.3 738 (50.5) 110,267 (96.3) 0.7
Minnesota 68,610 1,050 1.5 558 (53.1) 66,159 (96.4) 0.8
Mississippi 40,036 163 0.4 95 (58.3) 38,669 (96.6) 0.2
Missouri 76,759 672 0.9 339 (50.4) 73,905 (96.3) 0.5
Montana 12,060 105 0.9 51 (48.6) 11,695 (97.0) 0.4
Nebraska 25,918 210 0.8 97 (46.2) 25,021 (96.5) 0.4
Nevada 35,934 479 1.3 238 (49.7) 34,760 (96.7) 0.7
New Hampshire 12,874 288 2.2 174 (60.4) 12,359 (96.0) 1.4
New Jersey 106,922 3,803 3.6 1,963 (51.6) 102,021 (95.4) 1.9
New Mexico 27,850 229 0.8 103 (45.0) 27,103 (97.3) 0.4
See table footnotes on page 18.
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TABLE 3. (Continued) Number, percentage, and proportion of infants born with the use of assisted reproductive technology (ART), by female 
patient’s state/territory of residence* at time of treatment — United States, 2010† 
Patient’s state/territory of 
residence 
No. infants  
born§
No. ART 
infants born 
Proportion of 
infants born 
who are ART 
infants  
(%) 
ART  
singleton  
infants¶
Singletons  
among all  
infants§
Proportion of 
ART singletons 
among all 
singletons  
(%)No. (%) No. (%)
New York§§ 123,678 4,672 3.8 2,753 (58.9) 118,630 (95.9) 2.3
New York City 120,697 1,586 1.3 954 (60.2) 116,126 (96.2) 0.8
North Carolina 122,350 1,455 1.2 718 (49.3) 118,063 (96.5) 0.6
North Dakota 9,104 87 1.0 51 (58.6) 8,813 (96.8) 0.6
Ohio 139,128 1,512 1.1 781 (51.7) 134,103 (96.4) 0.6
Oklahoma 53,238 369 0.7 171 (46.3) 51,535 (96.8) 0.3
Oregon 45,540 560 1.2 265 (47.3) 44,014 (96.6) 0.6
Pennsylvania†† 143,321 2,162 1.5 1,164 (53.8) 138,009 (96.3) 0.8
Puerto Rico 42,153 83 0.2 48 (57.8) 41,382 (98.2) 0.1
Rhode Island 11,177 239 2.1 125 (52.3) 10,774 (96.4) 1.2
South Carolina 58,342 521 0.9 255 (48.9) 56,415 (96.7) 0.5
South Dakota 11,811 98 0.8 60 (61.2) 11,438 (96.8) 0.5
Tennessee 79,495 458 0.6 275 (60.0) 76,998 (96.9) 0.4
Texas 386,118 4,347 1.1 2,075 (47.7) 374,047 (96.9) 0.6
Utah 52,258 522 1.0 233 (44.6) 50,567 (96.8) 0.5
Vermont 6,223 93 1.5 51 (54.8) 6,009 (96.6) 0.8
Virgin Islands 1,600 — 0.7 — (81.8) 1,562 (97.6) 0.6
Virginia 103,002 1,931 1.9 1,096 (56.8) 99,226 (96.3) 1.1
Washington 86,539 1,318 1.5 677 (51.4) 83,677 (96.7) 0.8
West Virginia 20,470 124 0.6 74 (59.7) 19,863 (97.0) 0.4
Wisconsin 68,487 568 0.8 282 (49.6) 66,225 (96.7) 0.4
Wyoming 7,556 44 0.6 22 (50.0) 7,327 (97.0) 0.3
Total 4,046,553 59,119 1.5 31,672 (53.6) 3,907,633 (96.5) 0.8
 * In cases of missing residency data (4%), the patient’s state of residency was assigned as the state in which the ART procedure was performed. 
 † Includes infants conceived from ART procedures performed in 2009 and born in 2010, and infants conceived from ART procedures performed in 2010 and born in 
2010. Total ART births exclude nonresidents. 
 § Source: US natality file, CDC, National Center for Health Statistics. U.S. births include nonresidents.
 ¶ ART singletons include singletons from singleton gestations only.  
 ** Data are not provided to preserve confidentiality but are included in totals.
 †† A substantial percentage (5%–33%) of residency information was missing for procedures performed in these four states.  
 §§ Outcomes for New York state do not include New York City.  
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TABLE 4. Number, percentage, and proportion of multiple-birth, twins, and triplets (plus) infants born with use of assisted reproductive 
technology (ART) procedure, by female patient’s place of residence* — United States, 2010†
Patient’s state/
territory of 
residence
Proportion 
of ART 
multiple-
birth 
infants 
among all 
multiple-
birth 
infants  
(%) 
Proportion 
of ART  
twin 
infants 
among all 
twin 
infants  
(%)
Proportion 
of ART 
triplet (plus) 
infants 
among all 
triplet (plus) 
infants  
(%)
ART  
triplet (plus) 
infants§
Triplet (plus) 
infants among 
all infants¶
ART  
twin  
infants§
Twin 
infants  
among all 
infants¶
ART  
multiple-birth  
infants§
Multiple-birth 
infants  
among all 
infants¶
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Alabama 163 (44.3) 2,209 (3.7) 7.4 148 (40.2) 2,118 (3.5) 7.0 —** (4.1) 91 (0.2) 16.5
Alaska 23 (38.3) 343 (3.0) 6.7 20 (33.3) 336 (2.9) 6.0 — (5.0) — (0.1) 42.9
Arizona 454 (49.3) 2,526 (2.9) 18.0 406 (44.1) 2,446 (2.8) 16.6 48 (5.2) 80 (0.1) 60.0
Arkansas 83 (40.9) 1,081 (2.8) 7.7 80 (39.4) 1,059 (2.7) 7.6 — (1.5) 22 (0.1) 13.6
California 3,468 (46.0) 15,931 (3.1) 21.8 3,251 (43.1) 15,335 (3.0) 21.2 217 (2.9) 596 (0.1) 36.4
Colorado 525 (52.8) 2,226 (3.4) 23.6 489 (49.2) 2,140 (3.2) 22.9 36 (3.6) 86 (0.1) 41.9
Connecticut 637 (45.4) 1,771 (4.7) 36.0 598 (42.6) 1,689 (4.5) 35.4 39 (2.8) 82 (0.2) 47.6
Delaware 70 (34.3) 413 (3.6) 16.9 70 (34.3) 395 (3.5) 17.7 0 (0) — (0.2) 0
District of 
Columbia
148 (43.9) 421 (4.6) 35.2 142 (42.1) 403 (4.4) 35.2 — (1.8) 18 (0.2) 33.3
Federated States 
of Micronesia
— — — — — — — — — — — — — — —
Florida 1,176 (49.0) 6,778 (3.2) 17.4 1,102 (45.9) 6,533 (3.0) 16.9 74 (3.1) 245 (0.1) 30.2
Georgia†† 693 (49.9) 4,665 (3.5) 14.9 654 (47.1) 4,530 (3.4) 14.4 39 (2.8) 135 (0.1) 28.9
Guam — (0) 46 (1.3) 0 — (0) 46 (1.3) 0 0 (0) 0 (0) —
Hawaii†† 116 (49.2) 588 (3.1) 19.7 116 (49.2) 570 (3.0) 20.4 0 (0) 18 (0.1) 0
Idaho 131 (53.7) 732 (3.2) 17.9 116 (47.5) 703 (3.0) 16.5 — (6.1) 29 (0.1) 51.7
Illinois 1,716 (45.5) 6,371 (3.9) 26.9 1,602 (42.4) 6,111 (3.7) 26.2 114 (3.0) 260 (0.2) 43.8
Indiana 358 (50.8) 2,679 (3.2) 13.4 314 (44.5) 2,556 (3.0) 12.3 44 (6.2) 123 (0.1) 35.8
Iowa 229 (42.3) 1,418 (3.7) 16.1 220 (40.7) 1,343 (3.5) 16.4 — (1.7) 75 (0.2) 12.0
Kansas 160 (50.8) 1,224 (3.0) 13.1 139 (44.1) 1,173 (2.9) 11.8 21 (6.7) 51 (0.1) 41.2
Kentucky 229 (50.6) 1,798 (3.2) 12.7 202 (44.6) 1,727 (3.1) 11.7 27 (6.0) 71 (0.1) 38.0
Louisiana 205 (49.4) 2,134 (3.4) 9.6 181 (43.6) 2,030 (3.3) 8.9 24 (5.8) 104 (0.2) 23.1
Maine 24 (44.4) 400 (3.1) 6.0 24 (44.4) 388 (3.0) 6.2 0 (0) 12 (0.1) 0
Maryland 766 (41.3) 2,817 (3.8) 27.2 735 (39.6) 2,728 (3.7) 26.9 31 (1.7) 89 (0.1) 34.8
Massachusetts†† 1,349 (38.8) 3,330 (4.6) 40.5 1,297 (37.3) 3,223 (4.4) 40.2 52 (1.5) 107 (0.1) 48.6
Michigan 722 (49.5) 4,264 (3.7) 16.9 646 (44.2) 4,064 (3.5) 15.9 76 (5.2) 200 (0.2) 38.0
Minnesota 492 (46.9) 2,451 (3.6) 20.1 483 (46.0) 2,354 (3.4) 20.5 — (0.9) 97 (0.1) 9.3
Mississippi 68 (41.7) 1,367 (3.4) 5.0 68 (41.7) 1,351 (3.4) 5.0 0 (0) — (0) 0
Missouri 333 (49.6) 2,854 (3.7) 11.7 306 (45.5) 2,710 (3.5) 11.3 27 (4.0) 144 (0.2) 18.8
Montana 54 (51.4) 365 (3.0) 14.8 54 (51.4) 358 (3.0) 15.1 0 (0) — (0.1) 0
Nebraska 113 (53.8) 897 (3.5) 12.6 100 (47.6) 829 (3.2) 12.1 — (6.2) 68 (0.3) 19.1
Nevada 241 (50.3) 1,174 (3.3) 20.5 226 (47.2) 1,121 (3.1) 20.2 — (3.1) 53 (0.1) 28.3
New Hampshire 114 (39.6) 515 (4.0) 22.1 114 (39.6) 493 (3.8) 23.1 0 (0) 22 (0.2) 0
New Jersey 1,840 (48.4) 4,901 (4.6) 37.5 1,744 (45.9) 4,697 (4.4) 37.1 96 (2.5) 204 (0.2) 47.1
New Mexico 126 (55.0) 747 (2.7) 16.9 117 (51.1) 729 (2.6) 16.0 — (3.9) — (0.1) 50.0
New York§§ 1,919 (41.1) 5,048 (4.1) 38.0 1,763 (37.7) 9,159 (3.7) 25.9 156 (3.3) 460 (0.2) 38.5
New York City¶¶ 632 (39.8) 4,571 (3.8) 13.8 611 (38.5) 21 (1.3)
See table footnotes on page 20.
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TABLE 4. (Continued) Number, percentage, and proportion of multiple-birth, twins, and triplets (plus) infants born with use of assisted 
reproductive technology (ART) procedure, by female patient’s place of residence* — United States, 2010†
Patient’s state/
territory of 
residence
Proportion 
of ART 
multiple-
birth 
infants 
among all 
multiple-
birth 
infants 
(%) 
Proportion 
of ART  
twin 
infants 
among all 
twin 
infants  
(%)
Proportion 
of ART 
triplet (plus) 
infants 
among all 
triplet (plus) 
infants  
(%)
ART  
triplet (plus) 
infants§
Triplet (plus) 
infants among 
all infants¶
ART  
twin  
infants§
Twin infants  
among all 
infants¶
ART  
multiple-birth  
infants§
Multiple-birth 
infants  
among all 
infants¶
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
North Carolina 737 (50.7) 4,287 (3.5) 17.2 689 (47.4) 4,133 (3.4) 16.7 48 (3.3) 154 (0.1) 31.2
North Dakota 36 (41.4) 291 (3.2) 12.4 36 (41.4) 270 (3.0) 13.3 0 (0) 21 (0.2) 0
Ohio 731 (48.3) 5,025 (3.6) 14.5 649 (42.9) 4,743 (3.4) 13.7 82 (5.4) 282 (0.2) 29.1
Oklahoma 198 (53.7) 1,703 (3.2) 11.6 192 (52.0) 1,655 (3.1) 11.6 — (1.6) 48 (0.1) 12.5
Oregon 295 (52.7) 1,526 (3.4) 19.3 280 (50.0) 1,471 (3.2) 19.0 — (2.7) 55 (0.1) 27.3
Pennsylvania†† 998 (46.2) 5,312 (3.7) 18.8 931 (43.1) 5,107 (3.6) 18.2 67 (3.1) 205 (0.1) 32.7
Puerto Rico 35 (42.2) 771 (1.8) 4.5 26 (31.3) 744 (1.8) 3.5 — (10.8) 27 (0.1) 33.3
Rhode Island 114 (47.7) 403 (3.6) 28.3 111 (46.4) 391 (3.5) 28.4 — (1.3) — (0.1) 25.0
South Carolina 266 (51.1) 1,927 (3.3) 13.8 251 (48.2) 1,862 (3.2) 13.5 — (2.9) 65 (0.1) 23.1
South Dakota 38 (38.8) 373 (3.2) 10.2 32 (32.7) 355 (3.0) 9.0 — (6.1) — (0.2) 33.3
Tennessee 183 (40.0) 2,497 (3.1) 7.3 171 (37.3) 2,417 (3.0) 7.1 — (2.6) 80 (0.1) 15.0
Texas 2,272 (52.3) 12,071 (3.1) 18.8 2,093 (48.1) 11,513 (3.0) 18.2 179 (4.1) 558 (0.1) 32.1
Utah 289 (55.4) 1,691 (3.2) 17.1 269 (51.5) 1,625 (3.1) 16.6 20 (3.8) 66 (0.1) 30.3
Vermont 42 (45.2) 214 (3.4) 19.6 42 (45.2) 205 (3.3) 20.5 0 (0) — (0.1) 0
Virgin Islands — (18.2) 38 (2.4) 5.3 — (18.2) 38 (2.4) 5.3 0 (0) 0 (0)
Virginia 835 (43.2) 3,776 (3.7) 22.1 795 (41.2) 3,645 (3.5) 21.8 40 (2.1) 131 (0.1) 30.5
Washington 641 (48.6) 2,862 (3.3) 22.4 603 (45.8) 2,795 (3.2) 21.6 38 (2.9) 67 (0.1) 56.7
West Virginia 50 (40.3) 607 (3.0) 8.2 50 (40.3) 591 (2.9) 8.5 0 (0) — (0.1) 0
Wisconsin 286 (50.4) 2,262 (3.3) 12.6 265 (46.7) 2,163 (3.2) 12.3 21 (3.7) 99 (0.1) 21.2
Wyoming 22 (50.0) 229 (3.0) 9.6 22 (50.0) 220 (2.9) 10.0 0 (0) — (0.1) 0
Total 27,447 (46.4) 138,920 (3.4) 19.8 25,647 (43.4) 133,390 (3.3) 19.2 1,800 (3.0) 5,530 (0.1) 32.5
 * In cases of missing residency data (4%), the patient’s state of residency was assigned as the state in which the ART procedure was performed. 
 † ART totals include infants conceived from ART procedures performed in 2009 and born in 2010, and infants conceived from ART procedures performed in 2010 
and born in 2010. Total ART births exclude nonresidents. 
 § Includes only the number of infants live-born in a multiple-birth delivery. For example, if three infants were born in a live-birth delivery and one of the three infants 
was stillborn, the total number of liveborn infants would be two. However, the two infants still would be counted as triplets.
 ¶ Source: U.S. natality file, CDC, National Center for Health Statistics. U.S. totals include nonresidents.
 ** Data not provided to preserve confidentiality but included in totals. 
 †† A substantial percentage (5%–33%) of residency information was missing for procedures performed in these four states.
 §§ Outcomes for New York state do not include New York City.
 ¶¶ The total number of multiple birth infants in New York City cannot be separated into twins and triplets (plus); the number is reported as an aggregate that includes 
twins and higher-order multiple birth infants. 
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TABLE 5. Number, percentage, and proportion of infants born with use of assisted reproductive technology (ART), by low birthweight category 
and female patient’s place of residence* — United States, 2010†
Patient’s state/
territory of 
residence
<2,500 g (LBW) <1,500 g (VLBW) 1,500–2,499 g (MLBW)
Proportion 
of ART 
LBW 
infants 
among all 
LBW 
infants  
(%)
Proportion 
of ART 
VLBW 
 infants 
among all  
VLBW  
infants  
(%)
Proportion 
of ART 
MLBW 
infants 
among all 
MLBW 
infants  
(%)
ART  
infants§
All  
infants¶
ART  
infants§
All  
infants¶
ART  
infants§
All  
infants¶
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Alabama 125 (34.0) 6,165 (10.3) 2.0 31 (8.4) 1,176 (2.0) 2.6 94 (25.5) 4,989 (8.3) 1.9
Alaska —** (31.7) 651 (5.7) 2.9 — (5.0) 105 (0.9) 2.9 — (26.7) 546 (4.8) 2.9
Arizona 321 (34.9) 6,190 (7.1) 5.2 51 (5.5) 941 (1.1) 5.4 270 (29.3) 5,249 (6.0) 5.1
Arkansas 48 (23.6) 3,391 (8.8) 1.4 — (3.4) 599 (1.6) 1.2 41 (20.2) 2,792 (7.2) 1.5
California 2,223 (29.5) 34,641 (6.8) 6.4 341 (4.5) 5,791 (1.1) 5.9 1,882 (25.0) 28,850 (5.7) 6.5
Colorado 384 (38.6) 5,811 (8.8) 6.6 72 (7.2) 881 (1.3) 8.2 312 (31.4) 4,930 (7.4) 6.3
Connecticut 422 (30.1) 3,011 (8.0) 14.0 64 (4.6) 577 (1.5) 11.1 358 (25.5) 2,434 (6.5) 14.7
Delaware 61 (29.9) 1,016 (8.9) 6.0 — (7.4) 193 (1.7) 7.8 46 (22.5) 823 (7.2) 5.6
District of 
Columbia
94 (27.9) 934 (10.2) 10.1 — (5.6) 210 (2.3) 9.0 75 (22.3) 724 (7.9) 10.4
Florida 857 (35.7) 18,681 (8.7) 4.6 176 (7.3) 3,478 (1.6) 5.1 681 (28.4) 15,203 (7.1) 4.5
Georgia†† 528 (38.0) 12,912 (9.6) 4.1 72 (5.2) 2,361 (1.8) 3.0 456 (32.8) 10,551 (7.9) 4.3
Guam — — 294 (8.6) 0 — — 50 (1.5) 0 — — 244 (7.1) 0
Hawaii†† 92 (39.0) 1,584 (8.3) 5.8 — (7.2) 222 (1.2) 7.7 75 (31.8) 1,362 (7.20 5.5
Idaho 89 (36.5) 1,573 (6.8) 5.7 — (4.5) 241 (1.0) 4.6 78 (32.0) 1,332 (5.7) 5.9
Illinois 1,195 (31.7) 13,666 (8.3) 8.7 199 (5.3) 2,553 (1.5) 7.8 996 (26.4) 11,113 (6.7) 9.0
Indiana 235 (33.3) 6,732 (8.0) 3.5 43 (6.1) 1,189 (1.4) 3.6 192 (27.2) 5,543 (6.6) 3.5
Iowa 149 (27.5) 2,700 (7.0) 5.5 36 (6.7) 504 (1.3) 7.1 113 (20.9) 2,196 (5.7) 5.1
Kansas 101 (32.1) 2,881 (7.1) 3.5 21 (6.7) 487 (1.2) 4.3 80 (25.4) 2,394 (5.9) 3.3
Kentucky 151 (33.3) 5,044 (9.0) 3.0 41 (9.1) 903 (1.6) 4.5 110 (24.3) 4,141 (7.4) 2.7
Louisiana 148 (35.7) 6,700 (10.7) 2.2 29 (7.0) 1,257 (2.0) 2.3 119 (28.7) 5,443 (8.7) 2.2
Maine — (24.1) 814 (6.3) 1.6 — (1.9) 134 (1.0) 0.7 — (22.2) 680 (5.2) 1.8
Maryland 516 (27.8) 6,474 (8.8) 8.0 87 (4.7) 1,273 (1.7) 6.8 429 (23.1) 5,201 (7.0) 8.2
Massachusetts†† 900 (25.9) 5,634 (7.7) 16.0 150 (4.3) 949 (1.3) 15.8 750 (21.6) 4,685 (6.4) 16.0
Michigan 452 (31.0) 9,610 (8.4) 4.7 87 (6.0 1,818 (1.6) 4.8 365 (25.0) 7,792 (6.8) 4.7
Minnesota 278 (26.5) 4,415 (6.4) 6.3 38 3.6 737 (1.1) 5.2 240 (22.9) 3,678 (5.4) 6.5
Mississippi 53 (32.5) 4,852 (12.1) 1.1 — 4.3 847 (2.1) 0.8 46 (28.2) 4,005 (10.0) 1.1
Missouri 211 (31.4) 6,286 (8.2) 3.4 45 6.7 1,096 (1.4) 4.1 166 (24.7) 5,190 (6.8) 3.2
Montana 34 (32.4) 901 (7.5) 3.8 — 14.3 154 (1.3) 9.7 — (18.1) 747 (6.2) 2.5
Nebraska 68 (32.4) 1,839 (7.1) 3.7 — 7.6 329 (1.3) 4.9 52 (24.8) 1,510 (5.8) 3.4
Nevada 197 (41.1) 2,965 (8.3) 6.6 36 7.5 470 (1.3) 7.7 161 (33.6) 2,495 (6.9) 6.5
New Hampshire 65 (22.6) 881 (6.8) 7.4 — 4.2 147 (1.1) 8.2 53 (18.4) 734 (5.7) 7.2
New Jersey 1,279 (33.6) 8,814 (8.2) 14.5 236 6.2 1,636 (1.5) 14.4 1,043 (27.4) 7,178 (6.7) 14.5
New Mexico 95 (41.5) 2,427 (8.7) 3.9 22 9.6 371 (1.3) 5.9 73 (31.9) 2,056 (7.4) 3.6
See table footnotes on page 22.
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TABLE 5. (Continued) Number, percentage, and proportion of infants born with use of assisted reproductive technology (ART), by low birthweight 
category and female patient’s place of residence* — United States, 2010†
Patient’s state/
territory of 
residence
<2,500 g (LBW) <1,500 g (VLBW) 1,500–2,499 g (MLBW)
Proportion 
of ART 
LBW 
infants 
among all 
LBW 
infants  
(%)
Proportion 
of ART 
VLBW 
 infants 
among all  
VLBW  
infants  
(%)
Proportion 
of ART 
MLBW 
infants 
among all 
MLBW 
infants  
(%)
ART  
infants§
All  
infants¶
ART  
infants§
All  
infants¶
ART  
infants§
All  
infants¶
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
New York§§ 1,350 (28.9) 9,562 (7.7) 14.1 233 5.0 1,759 (1.4) 13.2 1,117 (23.9) 7,803 (6.3) 14.3
New York City 401 (25.3) 10,487 (8.7) 3.8 53 3.3 1,923 (1.6) 2.8 348 (21.9) 8,564 (7.10 4.1
North Carolina 484 (33.3) 11,109 (9.1) 4.4 94 6.5 2,081 (1.7) 4.5 390 (26.8) 9,028 (7.4) 4.3
North Dakota 25 (28.7) 607 (6.7) 4.1 — 9.2 105 (1.2) 7.6 — (19.5) 502 (5.5) 3.4
Ohio 501 (33.1) 11,899 (8.6) 4.2 110 7.3 2,303 (1.7) 4.8 391 (25.9) 9,596 (6.9) 4.1
Oklahoma 151 (40.9) 4,458 (8.4) 3.4 — 5.1 749 (1.4) 2.5 132 (35.8) 3,709 (7.0) 3.6
Oregon 168 (30.0) 2,865 (6.3) 5.9 24 4.3 472 (1.0) 5.1 144 (25.7) 2,393 (5.3) 6.0
Pennsylvania†† 658 (30.4) 11,941 (8.3) 5.5 127 5.9 2,309 (1.6) 5.5 531 (24.6) 9,632 (6.7) 5.5
Puerto Rico 40 (48.2) 5,304 (12.6) 0.8 — 13.3 544 (1.3) 2.0 29 (34.9) 4,760 (11.3) 0.6
Rhode Island 69 (28.9) 862 (7.7) 8.0 — 5.9 167 (1.5) 8.4 55 (23.0) 695 (6.2) 7.9
South Carolina 188 (36.1) 5,781 (9.9) 3.3 42 8.1 1,102 (1.9) 3.8 146 (28.0) 4,679 (8.0) 3.1
South Dakota 33 (33.7) 806 (6.8) 4.1 — 10.2 150 (1.3) 6.7 23 (23.5) 656 (5.6) 3.5
Tennessee 139 (30.3) 7,179 (9.0) 1.9 24 5.2 1,245 (1.6) 1.9 115 (25.1) 5,934 (7.5) 1.9
Texas 1,674 (38.5) 32,486 (8.4) 5.2 297 6.8 5,531 (1.4) 5.4 1,377 (31.7) 26,955 (7.0) 5.1
Utah 183 (35.1) 3,655 (7.0) 5.0 25 4.8 574 (1.1) 4.4 158 (30.3) 3,081 (5.9) 5.1
Vermont 25 (26.9) 382 (6.1) 6.5 — 4.3 66 (1.1) 6.1 21 (22.6) 316 (5.1) 6.6
Virgin Islands — (27.3) 141 (8.8) 2.1 — 9.1 27 (1.7) 3.7 — (18.2) 114 (7.1) 1.8
Virginia 543 (28.1) 8,448 (8.2) 6.4 92 4.8 1,588 (1.5) 5.8 451 (23.4) 6,860 (6.7) 6.6
Washington 399 (30.3) 5,464 (6.3) 7.3 66 5.0 876 (1.0) 7.5 333 (25.3) 4,588 (5.3) 7.3
West Virginia 37 (29.8) 1,880 (9.2) 2.0 — 4.0 270 (1.3) 1.9 32 (25.8) 1,610 (7.9) 2.0
Wisconsin 177 (31.2) 4,818 (7.0) 3.7 37 6.5 859 (1.3) 4.3 140 (24.6) 3,959 (5.8) 3.5
Wyoming 21 (47.7) 679 (9.0) 3.1 — 4.5 83 (1.1) 2.4 — (43.2) 596 (7.9) 3.2
Total 18,672 (31.6) 331,302 (8.2) 5.6 3,298 5.6 58,462 (1.4) 5.6 15,374 (26.0) 272,840 (6.7) 5.6
Abbreviations: LBW= low birthweight; MLBW= moderate low birthweight; VLBW = very low birthweight.
 * In cases of missing residency data (4%), the patient’s state of residency was assigned as the state in which the ART procedure was performed. 
 † ART totals include infants conceived from ART procedures performed in 2009 and born in 2010, and infants conceived from ART procedures performed in 2010 
and born in 2010. Total ART infants exclude nonresidents.
 § Includes only the number of infants live-born in a multiple-birth delivery. For example, if three infants were born in a live-birth delivery and one of the three infants 
was stillborn, the total number of live-born infants would be two. However, the two infants still would be counted as triplets.
 ¶ Source: US natality file, CDC, National Center for Health Statistics. U.S. totals include nonresidents.
 ** Data are not provided to preserve confidentiality but are included in totals.
 †† A substantial percentage (5%–33%) of residency information was missing for procedures performed in these four states.
 §§ Outcomes for New York state do not include New York City. 
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TABLE 6. Number, percentage, and proportion of infants born with use of assisted reproductive technology (ART), by low gestational age 
category and female patient’s place of residence* — United States, 2010†
Patient’s state/
territory of 
residence
<37 weeks (PTB) <32wks (VPTB) 32–36 wks (MPTB)
Proportion 
of  
ART  
MPTB 
infants 
among all 
MPTB 
infants  
(%)
Proportion 
of ART  
PTB 
infants 
among all 
PTB 
infants  
(%)
Proportion 
of ART 
VPTB 
infants 
among all 
VPTB 
infants  
(%)
ART  
infants§
All  
infants¶
ART  
infants§
All  
infants¶
ART  
infants§
All  
infants¶
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Alabama 148 (40.2) 9,360 (15.6) 1.6 38 (10.3) 1,652 (2.8) 2.3 110 (29.9) 7,708 (12.8) 1.4
Alaska 20 (33.3) 1,107 (9.7) 1.8 —** (5.0) 146 (1.3) 2.1 — (28.3) 961 (8.4) 1.8
Arizona 374 (40.6) 10,660 (12.2) 3.5 60 (6.5) 1,453 (1.7) 4.1 314 (34.1) 9,207 (10.5) 3.4
Arkansas 69 (34.0) 4,905 (12.7) 1.4 — (3.0) 728 (1.9) 0.8 63 (31.0) 4,177 (10.8) 1.5
California 2,573 (34.1) 50,355 (9.9) 5.1 418 (5.5) 7,421 (1.5) 5.6 2,155 (28.6) 42,934 (8.4) 5.0
Colorado 417 (42.0) 7,168 (10.8) 5.8 84 (8.5) 1,157 (1.7) 7.3 333 (33.5) 6,011 (9.1) 5.5
Connecticut 463 (33.0) 3,884 (10.3) 11.9 69 (4.9) 684 (1.8) 10.1 394 (28.1) 3,200 (8.5) 12.3
Delaware 56 (27.5) 1,456 (12.8) 3.8 — (7.4) 262 (2.3) 5.7 41 (20.1) 1,194 (10.5) 3.4
District of 
Columbia
103 (30.6) 1,248 (13.6) 8.3 — (5.0) 279 (3.0) 6.1 86 (25.5) 969 (10.6) 8.9
Florida 994 (41.4) 28,551 (13.3) 3.5 212 (8.8) 4,927 (2.3) 4.3 782 (32.6) 23,624 (11.0) 3.3
Georgia†† 552 (39.7) 18,363 (13.7) 3.0 98 (7.1) 3,045 (2.3) 3.2 454 (32.7) 15,318 (11.4) 3.0
Guam — — 612 (17.9) 0 — — 98 (2.9) 0 — — 514 (15.1) 0
Hawaii†† 111 (47.0) 2,315 (12.2) 4.8 21 (8.9) 338 (1.8) 6.2 90 (38.1) 1,977 (10.4) 4.6
Idaho 112 (45.9) 2,393 (10.3) 4.7 — (7.0) 322 (1.4) 5.3 95 (38.9) 2,071 (8.9) 4.6
Illinois 1,325 (35.1) 20,052 (12.1) 6.6 243 (6.4) 3,565 (2.2) 6.8 1,082 (28.7) 16,487 (10.0) 6.6
Indiana 308 (43.7) 9,845 (11.7) 3.1 61 (8.7) 1,641 (2.0) 3.7 247 (35.0) 8,204 (9.8) 3.0
Iowa 199 (36.8) 4,473 (11.6) 4.4 42 (7.8) 715 (1.8) 5.9 157 (29.0) 3,758 (9.7) 4.2
Kansas 116 (36.8) 4,306 (10.6) 2.7 29 (9.2) 665 (1.6) 4.4 87 (27.6) 3,641 (9.0) 2.4
Kentucky 187 (41.3) 7,662 (13.7) 2.4 49 (10.8) 1,225 (2.2) 4.0 138 (30.5) 6,437 (11.5) 2.1
Louisiana 176 (42.4) 9,400 (15.1) 1.9 33 (8.0) 1,653 (2.6) 2.0 143 (34.5) 7,747 (12.4) 1.8
Maine — (31.5) 1,259 (9.7) 1.4 0 (0) 209 (1.6) 0 — (31.5) 1,050 (8.1) 1.6
Maryland 602 (32.4) 9,398 (12.7) 6.4 94 5.1 1,676 (2.3) 5.6 508 (27.4) 7,722 (10.5) 6.6
Massachusetts†† 1,035 (29.7) 7,786 (10.7) 13.3 193 5.5 1,195 (1.6) 16.2 842 (24.2) 6,591 (9.0) 12.8
Michigan 527 (36.1) 14,010 (12.2) 3.8 96 6.6 2,478 (2.2) 3.9 431 (29.5) 11,532 (10.1) 3.7
Minnesota 353 (33.6) 6,980 (10.2) 5.1 56 5.3 1,074 (1.6) 5.2 297 (28.3) 5,906 (8.6) 5.0
Mississippi 66 (40.5) 7,037 (17.6) 0.9 — 8.6 1,125 (2.8) 1.2 52 (31.9) 5,912 (14.8) 0.9
Missouri 289 (43.0) 9,272 (12.1) 3.1 54 8.0 1,522 (2.0) 3.5 235 (35.0) 7,750 (10.1) 3.0
Montana 42 (40.0) 1,441 (11.9) 2.9 — 13.3 215 (1.8) 6.5 28 (26.70 1,226 (10.2) 2.3
Nebraska 94 (44.8) 2,951 (11.4) 3.2 — 8.6 454 (1.8) 4.0 76 (36.2) 2,497 (9.6) 3.0
Nevada 236 (49.3) 4,952 (13.8) 4.8 39 8.1 781 (2.2) 5.0 197 (41.1) 4,171 (11.6) 4.7
New Hampshire 68 (23.6) 1,202 (9.3) 5.7 — 4.5 189 (1.5) 6.9 55 (19.1) 1,013 (7.9) 5.4
New Jersey 1,420 (37.3) 12,419 (11.6) 11.4 266 7.0 2,215 (2.1) 12.0 1,154 (30.3) 10,204 (9.5) 11.3
New Mexico 89 (38.9) 3,317 (11.9) 2.7 20 8.7 477 (1.7) 4.2 69 (30.1) 2,840 (10.2) 2.4
See table footnotes on page 24.
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TABLE 6. (Continued) Number, percentage, and proportion of infants born with use of assisted reproductive technology (ART), by low gestational 
age category and female patient’s place of residence* — United States, 2010†
Patient’s state/
territory of 
residence
<37 weeks (PTB) <32wks (VPTB) 32–36 wks (MPTB)
Proportion 
of  
ART  
MPTB 
infants 
among all 
MPTB 
infants  
(%)
Proportion 
of ART  
PTB 
infants 
among all 
PTB 
infants  
(%)
Proportion 
of ART 
VPTB 
infants 
among all 
VPTB 
infants  
(%)
ART  
infants§
All  
infants¶
ART  
infants§
All  
infants¶
ART  
infants§
All  
infants¶
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
New York§§ 1,529 (32.7) 13,560 (11.0) 11.3 282 6.0 2,424 (2.0) 11.6 1,247 (26.7) 11,136 (9.0) 11.2
New York City 479 (30.2) 14,564 (12.1) 3.3 71 4.5 2,454 (2.0) 2.9 408 (25.7) 12,110 (10.0) 3.4
North Carolina 557 (38.3) 15,569 (12.7) 3.6 96 6.6 2,932 (2.4) 3.3 461 (31.7) 12,637 (10.3) 3.6
North Dakota 33 (37.9) 989 (10.9) 3.3 — 10.3 152 (1.7) 5.9 24 (27.6) 837 (9.2) 2.9
Ohio 542 (35.8) 17,007 (12.2) 3.2 115 7.6 3,056 (2.2) 3.8 427 (28.2) 13,951 (10.0) 3.1
Oklahoma 170 (46.1) 7,376 (13.9) 2.3 — 4.9 1,119 (2.1) 1.6 152 (41.2) 6,257 (11.8) 2.4
Oregon 212 (37.9) 4,529 (9.9) 4.7 35 6.3 665 (1.5) 5.3 177 (31.6) 3,864 (8.5) 4.6
Pennsylvania†† 754 (34.9) 16,250 (11.3) 4.6 165 7.6 2,857 (2.0) 5.8 589 (27.2) 13,393 (9.3) 4.4
Puerto Rico 39 (47.0) 7,019 (16.7) 0.6 — 14.5 920 (2.2) 1.3 27 (32.5) 6,099 (14.5) 0.4
Rhode Island 80 (33.5) 1,207 (10.8) 6.6 — 7.1 210 (1.9) 8.1 63 (26.4) 997 (8.9) 6.3
South Carolina 226 (43.4) 8,263 (14.2) 2.7 48 9.2 1,506 (2.6) 3.2 178 (34.2) 6,757 (11.6) 2.6
South Dakota 37 (37.8) 1,349 (11.4) 2.7 — 12.2 239 (2.0) 5.0 25 (25.5) 1,110 (9.4) 2.3
Tennessee 167 (36.5) 10,208 (12.8) 1.6 28 6.1 1,588 (2.0) 1.8 139 (30.3) 8,620 (10.8) 1.6
Texas 1,998 (46.0) 50,696 (13.1) 3.9 345 7.9 7,799 (2.0) 4.4 1,653 (38.0) 42,897 (11.1) 3.9
Utah 237 (45.4) 5,682 (10.9) 4.2 30 5.7 756 (1.4) 4.0 207 (39.7) 4,926 (9.4) 4.2
Vermont 26 (28.0) 524 (8.4) 5.0 — 2.2 93 (1.5) 2.2 24 (25.8) 431 (6.9) 5.6
Virgin Islands — (36.4) 201 (12.6) 2.0 — 9.1 33 (2.1) 3.0 — (27.3) 168 (10.5) 1.8
Virginia 683 (35.4) 11,969 (11.6) 5.7 104 5.4 2,088 (2.0) 5.0 579 (30.0) 9,881 (9.6) 5.9
Washington 442 (33.5) 8,785 (10.2) 5.0 85 6.4 1,253 (1.4) 6.8 357 (27.1) 7,532 (8.7) 4.7
West Virginia 42 (33.9) 2,480 (12.1) 1.7 8 6.5 363 (1.8) 2.2 34 (27.4) 2,117 (10.3) 1.6
Wisconsin 215 (37.9) 7,425 (10.8) 2.9 44 7.7 1,262 (1.8) 3.5 171 (30.1) 6,163 (9.0) 2.8
Wyoming 25 (56.8) 831 (11.0) 3.0 5 11.4 138 (1.8) 3.6 20 (45.5) 693 (9.2) 2.9
Total 21,638 (36.6) 486,622 (12.0) 4.4 3,924 6.6 79,493 (2.0) 4.9 17,714 (30.0) 407,129 (10.1) 4.4
Abbreviations: PTB = preterm birth; MPTB = moderate preterm birth; VPTB = very preterm birth.
 * In cases of missing residency data (4%), the patient’s state of residency was assigned as the state in which the ART procedure was performed. 
 † ART totals include infants conceived from ART procedures performed in 2009 and born in 2010, and infants conceived from ART procedures performed in 2010 
and born in 2010. Total ART births exclude nonresidents.
 § Includes only the number of infants live-born in a multiple-birth delivery. For example, if three infants were born in a live-birth delivery and one of the three infants 
was stillborn, the total number of live-born infants would be two. However, the two infants still would be counted as triplets.
 ¶ Source: U.S. Natality File, CDC, National Center for Health Statistics. U.S. totals include nonresidents.
 ** Data not provided to preserve confidentiality but included in totals.
 †† A substantial percentage (5%–33%) of residency information was missing for procedures performed in these four states.
 §§ Outcomes for New York state do not include New York City.  
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